In this issue:
Early treatment best in acute HCV?
Factors for late V reactivation
Fibroscan for assessing liver fibrosis severity
IFN-induced thrombocytopaenia: bleedings rare
On-treatment predictors of post-therapy HBeAg and HbsAg
Telaprevir improves SVR in nonresponders
PEG-IFN α-2b + RBV in older patients with chronic HCV
Early prediction of SVR in chronic HCV
Successful treatment of HCV-related cirrhosis
Please login below to download this issue (PDF)